You searched for "infection"
IVTA use in Behçet’s disease
This study aimed to evaluate the efficacy and safety of intravitreal triamcinolone acetonide (IVTA) injection (4mg/0.1ml) in controlling posterior segment inflammation in patients with Behçet’s disease. Medical records of consecutive patients diagnosed with Behçet’s who underwent IVTA between July 2005...
Muscle insertion measurement by ultrasound biomicroscopy
The aim of this study was to evaluate the accuracy of ultrasound biomicroscopy (UBM) preoperatively and postoperatively in patients having primary horizontal muscle surgery. Sixteen eyes of 15 patients with concomitant horizontal strabismus were evaluated; mean age 21.1 ±3.3 years,...Simulated intravitreal injection training – the way forward
1 December 2018
| Niamh Stone, Srilakshmi Sharma
|
EYE - Vitreo-Retinal
Simulated surgical training is now recommended in the training curricula of all ophthalmologists in the United Kingdom [1]. Simulated training allows for familiarisation with a procedure, exercises the discipline of repetition, allows the resolution of technical difficulties and enables refinement...
Thalamic infarcts and the associated neuro-ophthalmic sequelae
3 June 2021
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a retrospective review of clinical and imaging data from a stroke database over a 10-year period. Of those identified as having a thalamic infarction (n=342), 40 were found to have neuro-ophthalmic sequelae (11.7%). The neuro-ophthalmic sequelae reported...
Don’t ignore the black lesion! It might be mucormycosis
1 June 2017
| Tina Parmar
|
EYE - Cornea
Keeping mucormycosis infection in the foreground of your differential diagnosis, especially in those more vulnerable patients, will help save their lives if recognised and managed appropriately. Mucormycosis is a fulminant infection caused by the fungi of the family Mucoraceae. It...
Blurred vision post liver transplant: to blame the house cat or not?
1 October 2014
| Stephenie Tiew, Gideon Hirschfield, Ian Pearce, Nicholas Beare
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Strabismus, EYE - Refractive, EYE - Vitreo-Retinal
This article outlines a case of atypical ocular toxoplasmosis associated with immunosuppression. There were two potential sources of infection in this patient and we describe how we concluded which was the most likely. Case report A 33-year-old female was referred...
The results of the last survey Apr23
3 April 2023
| Amar Alwitry
|
EYE - General
*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. My thanks...
Use of botulinum toxin A in the treatment of intermittent exotropia
In this prospective cohort study, the authors aimed to evaluate the efficiency of botulinum toxin A (BTA) injection in the treatment of intermittent exotropia (IXT) and examine factors affecting treatment outcomes. Seventy-four patients diagnosed with any type of IXT were...
2018 update on intravitreal injections
1 December 2018
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this review article the authors have highlighted the standardised and structured approach to intravitreal injections (IVI) by examining the recent evidence-based literature. IVI is the most commonly performed procedure worldwide with low potential risk of endophthalmitis. IOP spikes are...
Late stromal rejection in DALK
This case series reported on late stromal rejections in eyes after uncomplicated deep anterior lamellar keratoplasties (DALKs). Four eyes of three patients experienced episodes of isolated stromal rejection 33 to 46 months after surgically uncomplicated DALKs and a minimum of...
Short-term outcome after intravitreal ranibizumab injections for ROP
1 December 2013
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is an interventional case series study of three premature babies (six eyes) with high risk prethreshold or threshold retinopathy of prematurity (ROP) with plus disease that received intravitreal ranibizumab injections for ROP. All infants received intravitreal ranibizumab injections of...
